The use of JAK vs TNF inhibitors shows no significant increase in the incidence of major adverse cardiovascular events in ...

During a live event, Mark J. Fesler, MD, and participants discussed selection and timing of initiation of JAK inhibitor ...

In part 1, experts explores how assessing individual risk factors is crucial in selecting the appropriate JAK inhibitor for ...

Many rheumatologic conditions such as rheumatoid arthritis and lupus often strike women during their reproductive years, with ...